Article info
PDFLetters
Subcutaneous furosemide as palliative treatment in patients with advanced and terminal-phase heart failure
- Correspondence to Dr Javier Galindo-Ocaña, Department of Internal Medicine, Hospital Universitario Virgen del Rocío, Avenida Manuel Siurot s/n., Sevilla 41013, Spain; galinx3{at}gmail.com
Citation
Subcutaneous furosemide as palliative treatment in patients with advanced and terminal-phase heart failure
Publication history
- Received June 13, 2012
- Revision received September 23, 2012
- Accepted November 19, 2012
- First published December 14, 2012.
Online issue publication
September 12, 2016
Article Versions
- Previous version (12 September 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions